KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Edwards Lifesciences (EW) Other Gross PP&E Adjustments (2019 - 2026)

Edwards Lifesciences has reported Other Gross PP&E Adjustments over the past 13 years, most recently at $841.6 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 17.69% year-over-year to $841.6 million; the TTM value through Dec 2025 reached $841.6 million, up 17.69%, while the annual FY2025 figure was $841.6 million, 17.69% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $841.6 million at Edwards Lifesciences, up from -$96.5 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $841.6 million in Q4 2025 and troughed at -$104.4 million in Q3 2024.
  • A 5-year average of $5.3 million and a median of -$89.3 million in 2021 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: dropped 17.22% in 2021 and later surged 580.4% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at -$92.1 million in 2021, then fell by 0.22% to -$92.3 million in 2022, then soared by 213.87% to $105.1 million in 2023, then surged by 580.4% to $715.1 million in 2024, then rose by 17.69% to $841.6 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for EW at $841.6 million in Q4 2025, -$96.5 million in Q3 2025, and -$99.0 million in Q2 2025.